tiprankstipranks
Sumitomo Dainippon Pharma Co Ltd (JP:4506)
:4506
Japanese Market
4506
Sumitomo Dainippon Pharma Co
RESEARCH TOOLSreports
Want to see JP:4506 full AI Analyst Report?

Sumitomo Dainippon Pharma Co (4506) Financial Statements

7 Followers

Sumitomo Dainippon Pharma Co Financial Overview

Sumitomo Dainippon Pharma Co's market cap is currently ¥681.86B. The company's EPS TTM is ¥268.99; its P/E ratio is 7.72; Sumitomo Dainippon Pharma Co is scheduled to report earnings on May 13, 2026, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 26Mar 25Mar 24Mar 23
Income Statement
Total Revenue¥ 398.83B¥ 453.29B¥ 314.56B¥ 555.54B¥ 560.03B
Gross Profit¥ 225.38B¥ 256.89B¥ 157.08B¥ 342.95B¥ 371.18B
Operating Income¥ 22.42B¥ 50.34B¥ -1.48B¥ 11.20B¥ 56.55B
EBITDA¥ 47.98B¥ 71.13B¥ 36.29B¥ 52.47B¥ 94.90B
Net Income¥ 23.63B¥ 106.86B¥ -314.97B¥ -74.51B¥ 56.41B
Balance Sheet
Cash & Short-Term Investments¥ 23.12B¥ 44.31B¥ 29.05B¥ 143.48B¥ 202.98B
Total Assets¥ 742.60B¥ 804.57B¥ 907.51B¥ 1.13T¥ 1.31T
Total Debt¥ 314.25B¥ 217.19B¥ 427.86B¥ 346.37B¥ 284.54B
Net Debt¥ 291.13B¥ 172.88B¥ 398.82B¥ 202.89B¥ 81.56B
Total Liabilities¥ 573.13B¥ 512.10B¥ 751.37B¥ 727.96B¥ 634.44B
Stockholders' Equity¥ 169.48B¥ 292.47B¥ 156.06B¥ 406.75B¥ 607.89B
Cash Flow
Free Cash Flow¥ 8.00B¥ 67.11B¥ -252.66B¥ 3.47B¥ 23.89B
Operating Cash Flow¥ 16.50B¥ 71.72B¥ -241.89B¥ 11.94B¥ 31.24B
Investing Cash Flow¥ 99.75B¥ 22.55B¥ 33.04B¥ -145.99B¥ -21.91B
Financing Cash Flow¥ -108.84B¥ -91.27B¥ 77.85B¥ 51.59B¥ -17.79B
Currency in JPY

Sumitomo Dainippon Pharma Co Earnings and Revenue History

Income Statement >

Sumitomo Dainippon Pharma Co Debt to Assets

Balance Sheet >

Sumitomo Dainippon Pharma Co Cash Flow

Cash Flow >

Sumitomo Dainippon Pharma Co Forecast EPS vs Actual EPS

Earnings >